# Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

> **NCT00004149** · PHASE2 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 37 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** arsenic trioxide

## Key facts

- **NCT ID:** NCT00004149
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004149, "Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00004149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*